J.-L. Lagrange

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.

Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial

Gastric cancer

Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres

Symptom Clusters in Cancer Patients with Brain Metastases

Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

Relationships between body composition parameters and fluorouracil pharmacokinetics

Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication

Sensitive MS/MS–liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma

Definition and classification of cancer cachexia: an international consensus

Current Strategies in Whole-brain Radiation Therapy for Brain Metastases

Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.

Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

A new, validated HPLC‐MS/MS method for the simultaneous determination of the anti‐cancer agent capecitabine and its metabolites: 5′‐deoxy‐5‐fluorocytidine, 5′‐deoxy‐5‐fluorouridine, 5‐fluorouracil and 5‐fluorodihydrouracil, in human plasma

Cellular processing of platinum anticancer drugs

The pathobiology of mucositis

How to calculate the dose of chemotherapy

Analysis of anticancer drugs: A review

Targeting autophagy in cancer

Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

A new approach to dose escalation in non–small-cell lung cancer

Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine S-1 on a Once-Daily-for-28-Day Schedule in Patients with Advanced Malignancies

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context

Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity

Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial

Dose translation from animal to human studies revisited

Localized adenocarcinoma of the lung: A retrospective study of 186 non-metastatic patients from the french federation of cancer institutes—the radiotherapy cooperative group

Population study of dihydropyrimidine dehydrogenase in cancer patients.

Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases

[Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer].

Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement.